
An International Publisher for Academic and Scientific Journals
Author Login
Scholars Journal of Applied Medical Sciences | Volume-4 | Issue-06
Thyroid Cytology- Diversity of the Category “atypia of undetermined significance/ follicular lesion of undetermined significance”
Dr. Bimalka Seneviratne
Published: June 27, 2016 |
141
120
DOI: 10.36347/sjams.2016.v04i06.004
Pages: 1884-1887
Downloads
Abstract
Fine needle aspiration cytology (FNAC) is a well-established diagnostic technique for the preoperative
evaluation of thyroid nodules allowing a significant reduction in the number of surgical operations. Over the past few
decades, FNAC has developed as the most accurate and cost effective initial method for guiding the clinical management
of patients with disorders of the thyroid gland. However, the Bethesda category III (atypia of undetermined significance/
follicular lesion of undetermined significance) of thyroid cytology is somewhat heterogeneous and includes different
pathological entities.A retrospective study done over a period of 2 years. Study sample included 87 patients with a
cytological diagnosis of “atypia of undetermined significance/ follicular lesion of undetermined significance”.
Subsequent histological assessment of the study sample showed several well distinct pathological entities. The majority
of cases (80.45 %) in category III were histologically proven to be non-neoplastic while 19.52% was confirmed as
neoplastic. Among the neoplastic lesions 13.78 % was benign while 5.74 % was proven to be malignant. There was no
significant difference in the age, sex, site and size of the lesion between the benign and malignant categories. According
to the results of the present study the category III of Bethesda classification was somewhat indefinite in arriving at a
precise diagnosis to plan out the surgical management. Clinical details were not reliable in separating the benign and
malignant groups of category III. Hence we recommend radiological correlation of the thyroid lesion in identifying the
high risk patients.